Wedbush Securities Reacts To Regulus Therapeutics Inc Announcing ATHENA Natural History Study

By: via Benzinga
In a report published Friday, Wedbush Securities analyst Liana Moussatos reiterated an Outperform rating and $19.00 price target on ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.